On the molecular mechanism of the antiviral activity of trifluorothymidine.
D000998:Antiviral Agents; D004279:DNA, Viral / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008970:Molecular Weight; D012333:RNA, Messenger / Q000096:biosynthesis; D012367:RNA, Viral / Q000096:biosynthesis; D018139:Simplexvirus / Q000187:drug effects; D013329:Structure-Activity Relationship; D013936:Thymidine / Q000031:analogs & derivatives*; D014271:Trifluridine / Q000494:pharmacology / Q000627:therapeutic use*; D014616:Vaccinia virus / Q000187:drug effects / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D012333:RNA, Messenger; D012367:RNA, Viral; D007065:Idoxuridine; D014271:Trifluridine; D013936:Thymidine